International Stem Cell Corporation Announces Next Phase of Research Collaboration With Rohto Pharmaceutical Co., Ltd. of Japan

CARLSBAD, CA–(Marketwired – September 08, 2015) – International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com, ISCO or the Company), a California-based biotechnology company developing novel stem cell-based therapies, announced today …

[Read the full article here]

Comments are closed.